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ABSTRACT: Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disease which 
affects about over 30 million people worldwide. There is no suitable treatment for AD nowadays. The current 
scenario of the research in the field of the search for suitable therapeutic approaches for the treatment of 
Alzheimer’s disease should be a shift towards the combinatorial approach of Ayurveda and Yoga. This review 
is mainly focused on to adapt Ayurveda and Yoga approaches for the treatment of Alzheimer’s disease. 
Keywords: Neurodegenerative disease; Alzheimer’s disease; Ayurveda; Yoga; Therapeutic approaches. 
1. INTRODUCTION 
Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is 
the leading cause of AD that affects about over 30 million people worldwide [1]. According to the world 
Alzheimer report 2018, new case of dementia develops in every three seconds around the world. AD is a 
major disease that has no effective ways to cure, reverse and slowdown of disease progression once symptoms 
start. AD is the multifactorial disease in which genetic and environment both involve [2] and progression of 
inflammation is significant cause of the pathogenesis of the AD [3]. In AD patients, there are three more 
common changes are appeared in the brain tissues as neurofibrillary tangle, neuritic plaques and senile 
plaques. AD affects the three mains processes that keep neurons healthy as communication, metabolism and 
repair. The degeneration of the nerve cells is responsible to cause the memory loss, personality changes and 
problems in routine workout etc. Many researchers are used multi-target strategies for the treatment of AD 
such as β-amyloid peptide aggregation inhibitors, γ and β-secretase inhibitors & modulators, anti-amyloid 
immunotherapy, tau hyperphosphorylation inhibitors (e.g. JNK3, CDK5, GSK3β & Fyn kinase), tau 
aggregation inhibitors, microtubules stabilization, anti-tau immunotherapy, AChE inhibitors, 5-HT6 
antagonism, anti-diabetic/metabolic regulation therapies and Cdk5 inhibitors but these approaches have a 
limited success to cure the AD [4]. In this article, we have tried to collect an ample data that demonstrates 
Ayurveda and Yoga are significantly contributed in several distinctive treatment modalities for the 
Alzheimer’s treatment, in spite the use of above medicinal treatments. We have initially discussed about 
various ayurvedic medicinal therapeutics approaches that effective to prevent the AD progression and then 
discussed the several yoga practices which significant for AD’s treatment. 
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2. AYURVEDIC THERAPEUTIC APPROACHES IN AD 
In Ayurveda, various herbal formulations in which Rasayana is essential for management of mental 
and cognitive disorders including AD [5]. The Rasayana is mainly focused to enhance oxygenation that helps 
to promote neurogenesis by the homeostatic regulation re-establishment [6]. It can be noticed that the 
Ayurvedic medicinal therapeutics approaches are showed the same mechanisms to the modern medicine in a 
mechanistic study and effective to prevent the AD progression at some extent through various ways showing 
in Figure 1. They are bio-available and comparatively less toxic. Ayurveda drugs are not only modulated the 
neuro-endocrine-immune system but also provide rich source of antioxidant, strengthen cognitive power and 
memory and improve intellects [7]. Affluent sources of anti-oxidant, anti-amyloidogenic, anti-inflammatory, 
neuroprotective and immunomodulatory compounds are found in Ayurvedic nootropic herbs and 
formulations. The researchers have been found that these features are essential to modulate the neuro-immune 
activities, enhance memory, intellect, rejuvenate brain functions, allay neurodegenerative cascades of AD and 
improve quality life [8]. In recent times, some phytodrugs have been methodically tested in in-vivo and in-
vitro models of AD and also in clinical trials. Ginkgo biloba, Curcuma longa, Withania somnifera, Angelica 
sinensis extracts have been found to regulate APP metabolism towards α-secretase pathway and even restrict 
the formation, extension and stabilization of Aβ fibrils. These studies might be provided significant lead for 
the discovering an appropriate medicine for AD [9]. For the treatment of AD, Ginkgo biloba has been under 
prevention trials [10, 11]. Some study has reported that three plants Buchanania axillaris Desr. 
(Anacardiaceae), Hemidesmus indicus Linn. (Apocynaceae) and Rhus mysorensis Heyne (Anacardiaceae) 
were identified as multifunctional therapeutics remedy for the treatment of AD [12]. It has found that Bramhi 
Ghrita has features like as improving cognition, anti-inflammatory properties, clearance of small channels, 
rejuvenator and blood purification that is perfect for clearing up the toxic metabolic byproducts in the brain 
and also work to stop neurodegeneration and to support neuroprotection [13].  
Several studies have been shown that ayurvedic medicines play a vital role to treat the AD such as 
Gingko biloba for slow progression of AD, Galanthus caucasicus for treating memory impairments, Huperzia 
serrata for improving memory and mental functioning in AD patients, Catharanthus roseus for treating 
memory loss and mental impairments, Melissa officinalis for improving cognitive function and reducing the 
agitation, Curcuma longa (curcumin) increases phagocytosis of amyloid-beta that effectively clearing them 
from the brains of patients with AD and Withania somnifera (Ashwagandha) for stopping reverse and 
removing the neuritic atrophy and synaptic loss that is the main cause of neurodegeneration [14]. In recent 
years, some studies have been reported that AD disease could be treated by biomolecules extracted by plants 
such as kaempferol, is flavonoid, have been found to reduce the neurotoxic motor and cognitive impairments 
in AD flies [15] and oleanolic acid extracted from a Chinese herb, is pentacyclic triterpene, found to enhance 
Aβ induced memory loss and to restore synaptic plasticity in AD rats [16]. Various isolated compounds 
(alkaloids) have extracted from Esenbeckia leiocarpa (Rutaceae) [17], Coptidis rhizoma [18] and Corydalis 
cava (Fumariaceae) [19, 20] plants that were reported for acetylcholinesterase and butyrylcholinesterase 
inhibitory activity.  
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Figure 1. Synergistic neuroprotective effect of Ayurvedic herbs and Yoga practices on AD progression through various 
aspects. 
3. ANTI-OXIDANT PROPERTY 
Anti-oxidant present in ayurvedic plants are scavenged the free radicals, which are played vital role 
in the progression of Alzheimer’s disease. Many ayurvedic herbs are contained wide range of bioactive 
compounds that have a strong anti-oxidant and neuroprotective properties (Table 1) such as Terminalia 
chebula [21], Passiflora incarnata [22], Typhonium trilobatum [23], Satureja cuneifolia [24], Anisomeles 
indica [25], Curcuma longa [26], Bacopa monnieri [27], Crocus sativus L. [28, 29] Macrosphyra longistyla 
[30], Cinnamomum zeylanicum [31], Melissa officinalis [32, 33], Caesalpinia crista [34], Camellia sinensis 
[35], Scoparia dulcis [35]. These medicinal plants can be a potent alternative drug for Alzheimer’s disease 
treatment.  
4. ANTI-AMYLOIDOGENIC PROPERTY   
Natural extracts (e.g. polyphenols, alkaloids, cannabinoid) of medicinal plants that have shown anti-
amyloidogenic activities which is crucial to potent drug discovery to treat the AD without any side effects. 
These medicinal plants are Grewia tiliaefolia [36], Cassia tora [37], Elettaria cardamomum [38], Caesalpinia 
crista [39], Perilla frutescens [40], Guettarda speciose [41], Dryopteris crassirhizoma [42], Dracoephalum  
moldavica L. [43], Bacopa monnieri (L.) Wettst [44], Perilla frutescens [45], Lawsonia inermis [46], 
Sargassum horridum [47] that involve in anti-amyloid activity (Table 1).  
5. ANTI-INFLAMMATORY PROPERTY   
Various medicinal plants extract (polyphenols, alkaloids, cannabinoid) has shown anti-inflammatory 
activities in in-vitro/vivo experiments which is vital to develop a potential drug to treat the AD with no any 
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side effects. These medicinal plants are Terminalia chebula [21], Crocus sativus L. [28, 29], Lagerstroemia 
indica [48], Limonium spathulatum [49], Okinawa propolis [50], Corydalis dubia [51], Pancratium parvum 
[52] that reducing the inflammatory effects in brain tissues (Table 1). 
6. NEUROPROTECTIVE PROPERTY 
Alkaloids, flavonoids and phenolic acids, secondary metabolites of plants, are played a major role in 
improving regeneration or inhibiting neurodegeneration [53]. The plants compounds with neuroprotective 
property are widespread in clinical use but many is undergoing in clinical trials for the treatment of AD 
include nerve growth factor, valproate and other GSK inhibitors, various nicotinic agonists, the CEP-1347 
stress kinase inhibitor, minocycline as caspase inhibitor and metal chelators [54]. Bacopa monnieri (L.) Wettst 
[44], Grewia tiliaefolia [55], Vernonia amygdalina [56], Levisticum officinale [57], Schisandra chinensis [58], 
Withania somnifera [59], Ginkgo biloba [60], Kigelia africana [61] have the potentials of the neuroprotection 
through the improving regeneration of the neuron cells and inhibiting the neurodegeneration (Table 1).  
 
Table 1. Showing the name and type of herbal compounds used in in-vivo/in-vitro and their properties.   
Botanical name  










Passiflora incarnata Butanolic In-vitro Antioxidant [22] 
Typhonium trilobatum Flavonoids In-vitro Antioxidant [23] 
Satureja cuneifolia Phenolic In-vitro Antioxidant [24] 




Curcuma longa Hydroxynonenal In-vivo Antioxidant [26, 35] 
Bacopa monnieri 
Bacoside A, Bacoside B, 
Bacosaponins, Betulinic acid 
In-vivo Neuroprotective [27] 































Camellia sinensis Catechin In-vitro Antioxidant [35] 
Scoparia dulcis Flavones In-vitro Anti-amyloidogenic [35] 














Perilla frutescens Asarone In-vitro Anti-amyloidogenic [40] 
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Botanical name  









Dryopteris crassirhizoma Butanolic In-vitro Anti-amyloidogenic [42] 
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Okinawa propolis Flavonoids In-vivo Anti-inflammatory [50] 













































7. YOGA PRACTICES ARE VITAL IN AD 
Yoga is a non-religious mind-body approach of ancient India that integrates the spiritual, mental and 
physical components to improve the health and well-being [62, 63]. Yoga has several essential benefits and 
positive impactful for various body systems such as musculoskeletal system, cardiopulmonary, nervous and 
endocrine systems. Meditation has great potentials in stress reducing effects that is the beneficial for 
preventing cognitive and memory loss. Stress is depended upon the level of cortisol in body that responsible 
to progression of the Alzheimer’s disease, which can be regulated by a regular practice of meditation, 
however, very limited studies have been conducted with Alzheimer’s patients [64]. Some neurotransmitters 
secreted during the Yoga that provides the potential biological mechanism, which is responsible to 
improvement in AD neuropathology [65]. There has been found that long-term aerobic exercise has the 
potential to increase cognitive functioning and decreases in the hippocampal loss that help in prevention of the 
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AD [66] and the aerobic exercise may also a necessary part of the treatment for AD [67]. It can be noted that 
the aerobic training induces important beneficial effects on health that improving the executive function, 
attentional capacity, processing speed, episodic memory and procedural memory [68-70]. Several studies have 
been reported that physical exercise may be able to prevent and reverse these behavioral impairments in 
specific model of AD [70] and reducing the symptoms of dementia [71]. A recent study is presented that 
meditation may present themselves significant role for improving cognition and related outcomes in AD 
patients [72]. 
8. CONCLUSION 
The current scenario of the research in the field of the search of suitable therapeutic approaches for 
the treatment of Alzheimer’s disease should be shift towards the combinatorial approach of Ayurveda and 
Yoga, the reason behind this is that, there is no side effect of anyone out of these two, while these must be 
beneficial for any type of human disease. Non-drug interventions like memory training, mental and social 
stimulation and physical exercise programs could be possibly improved people’s cognitive performance [73]. 
By going through different available literature on concern topic, we found that Ayurvedic therapeutic 
approaches and Yoga practices have been widely used for the health promotion, disease prevention and 
possible treatment of the Alzheimer’s disease. Many Ayurvedic formulations, they are bio-available, have 
been used for modifying the treatment of AD. They have many special features like less toxic, anti-oxidant, 
anti-amyloidogenic, anti-inflammatory, neuroprotective and immunomodulatory that are essential to discover 
appropriate potent drugs for the AD and also significant for reduction in the cost and time. Many studies have 
shown that yoga is vital for treating the neurodegenerative disorders by several combine yogic exercises. The 
combination of the Ayurveda and Yoga would provide significant outcome for noble strategy of the treatment 
of Alzheimer’s disease. These combinations might be proved to provide the better panacea for AD in future.  
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